MEI Pharma Inc - Real-time stock metrics, market data, and comprehensive analysis
Fetching stock data...
MEI Pharma, Inc. is a pharmaceutical company with a portfolio of several drug candidates that may offer novel and differentiated cancer therapies. The drug candidate pipeline includes voruciclib, an oral cyclin-dependent kinase 9 inhibitor.
No news available